Integral Molecular Appoints Cheryl Paes to Drive Commercial Strategy Forward Integral Molecular welcomes Cheryl Paes as Vice President of Commercial Strategy. Her extensive experience will enhance the company’s biotech initiatives and partnerships for growth.

Integral Molecular Appoints Cheryl Paes to Drive Commercial Strategy Forward #United_States #Philadelphia #Integral_Molecular #Cheryl_Paes #commercial_strategy

Integral Molecular's Membrane Proteome Array Advances Toward FDA Qualification Integral Molecular is one step closer to obtaining FDA qualification for its Membrane Proteome Array, a vital tool in drug development to assess antibody specificity.

Integral Molecular's Membrane Proteome Array Advances Toward FDA Qualification #USA #Philadelphia #Integral_Molecular #Membrane_Proteome_Array #FDA_Qualification

Revolutionizing Virus Neutralization Testing: Integral Molecular's Ready Reporter Virus™ Kit Launches Integral Molecular has introduced the Ready Reporter Virus™ Kit, enabling virus neutralization testing up to 10 times faster than traditional methods, revolutionizing vaccine research.

Revolutionizing Virus Neutralization Testing: Integral Molecular's Ready Reporter Virus™ Kit Launches #USA #Philadelphia #Integral_Molecular #Ready_Reporter_Virus #Virus_Neutralization

Integral Molecular's Breakthrough Antibody Panel for Diabetes Treatment Integral Molecular announces a pioneering antibody panel targeting SLC2A4, enhancing prospects for diabetes therapies. This innovation paves the way for effective treatments for difficult-to-target diabetes proteins.

Integral Molecular's Breakthrough Antibody Panel for Diabetes Treatment #United_States #Philadelphia #Integral_Molecular #SLC2A4 #GLUT4

Integral Molecular Celebrated as a Top Workplace by Philadelphia Inquirer in 2025 Integral Molecular has been honored as a 2025 Top Workplace by the Philadelphia Inquirer, emphasizing its supportive culture and commitment to employee development.

Integral Molecular Celebrated as a Top Workplace by Philadelphia Inquirer in 2025 #United_States #Philadelphia #Top_Workplace #Integral_Molecular

Integral Molecular Introduces Paratope-PLUS™, a Game-Changer for Antibody Patent Claims and Engineering Integral Molecular has launched Paratope-PLUS™, an innovative CDR-scanning service designed to enhance antibody patent claims and engineering efforts.

Integral Molecular Introduces Paratope-PLUS™, a Game-Changer for Antibody Patent Claims and Engineering #United_States #Philadelphia #Integral_Molecular #Paratope-PLUS™ #antibody_engineering

Integral Molecular's Bispecific Antibody Set to Transform Cancer Treatment in Clinical Trials Integral Molecular announces the launch of clinical trials for its bispecific antibody, CTIM-76, targeting solid tumors in patients with specific cancers.

Integral Molecular's Bispecific Antibody Set to Transform Cancer Treatment in Clinical Trials #USA #Philadelphia #Cancer_Treatment #Integral_Molecular #CTIM-76

FDA Accepts Integral Molecular's Membrane Proteome Array Qualification to Boost Drug Development Safeguards Integral Molecular celebrates FDA's acceptance of its Membrane Proteome Array™ as a pivotal Drug Development Tool, enhancing drug safety evaluations.

FDA Accepts Integral Molecular's Membrane Proteome Array Qualification to Boost Drug Development Safeguards #USA #Philadelphia #Drug_Development #Integral_Molecular #Membrane_Proteome_Array

Integral Molecular Earns Employer of Choice Recognition in Philadelphia for Workforce Commitment Integral Molecular has been honored as an Employer of Choice by Philadelphia, showcasing its dedication to workforce development and innovation.

Integral Molecular Earns Employer of Choice Recognition in Philadelphia for Workforce Commitment #United_States #Philadelphia #Workforce_Development #Integral_Molecular